A rare case of multisystem inflammatory syndrome in adults-a diagnostic dilemma
DOI:
https://doi.org/10.18203/2349-3933.ijam20220382Keywords:
Multisystem inflammatory syndrome, MIS, Post-COVID infectionAbstract
Multisystem inflammatory syndrome (MIS) is a rare and severe post-infectious inflammatory disorder involving multiple systems (cardiovascular, gastrointestinal, dermatologic, nervous system, and haematological) without significant respiratory involvement. It is predominantly seen in children but sometimes in adults, usually after 3-6 weeks of COVID-19 infection or vaccination. It is postulated to be due to immune dysregulation. This case report adds to the limited literature available on post COVID MIS in adults, emphasizing how to reach the diagnosis after ruling out other differentials. Timely initiation of treatment gives gratifying results in most patients.
Metrics
References
Morris SB, Schwartz NG, Patel P, Abbo L, Beauchamps L, Balan S, et al. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection - United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1450-6.
Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395:1607-8.
Nune A, Iyengar KP, Goddard C, Ahmed AE. Multisystem inflammatory syndrome in an adult following the SARS-CoV-2 vaccine (MIS-V). BMJ Case Rep. 2021;14:e243888.
Vogel TP, Top KA, Karatzios C, Hilmers DC, Tapia LI, Moceri P, et al. Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2021;39:3037-49.
Patel P, De Cuir J, Abrams J, Campbell AP, Godfred-Cato S, Belay ED. Clinical Characteristics of Multisystem Inflammatory Syndrome in Adults: A Systematic Review. JAMA Netw Open. 2021;4:e2126456.
Hechem, KE, Oteo JA, Raoult D, Silverman DJ, Blanco J. A Century of Rickettsiology: Emerging, Reemerging Rickettsioses, Clinical, Epidemiologic, and Molecular Diagnostic Aspects and Emerging Veterinary Rickettsioses. Ann N Y Acad Sci. 2006;1078:1-14.
Reinhart, K, Karzai, W, Meisner, M. Procalcitonin is a marker of the systemic inflammatory response to infection. Intens Care Med. 2014;26:1193-200.
Godfred-Cato S, Bryant B, Leung J, Oster ME, Conklin L, Abrams J, et al. COVID-19-Associated Multisystem Inflammatory Syndrome in Children - United States, March-July 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1074-80.
Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N Engl J Med. 2020;383:334-46.
Poniecka A, Smolewska E. A fine line between macrophage activation syndrome and multisystem inflammatory syndrome in children - literature review based on two case reports. Reumatologia. 2021;59:47-57.
Centers for Disease Control and Prevention. Multisystem Inflammatory Syndrome in Adults (MIS-A) Case Definition Information for Healthcare Providers. 2021. Available at: https://www.cdc. gov/mis/mis-a/hcp.html. Accessed on 02 February 2022.
Madjid M, Safavi- Naeini P, Solomon SD, Vardeny O. Potential effects of Coronaviruses on the Cardiovascular System. A Review. JAMA Cardiol. 2020;5:831-40.
Bastug A, Aslaner H, Aybar Bilir Y, Kemirtlek N, Gursoy FM, Bastug S, et al. Multiple system inflammatory syndrome associated with SARS-CoV-2 infection in an adult and an adolescent. Rheumatol Int. 2021;41:993-1008.
Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, et al. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 1. Arthritis Rheumatol. 2020;72:1791-805.
Downloads
Published
How to Cite
Issue
Section
